UPK3B Antibody (Center) Blocking Peptide
Synthetic peptide
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | Q9BT76 |
---|---|
Clone Names | 110726267 |
Gene ID | 105375355 |
---|---|
Other Names | Uroplakin-3b, UP3b, Uroplakin IIIb, UPIIIb, p35, UPK3B |
Format | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
Name | UPK3B |
---|---|
Function | Component of the asymmetric unit membrane (AUM); a highly specialized biomembrane elaborated by terminally differentiated urothelial cells. May play an important role in AUM-cytoskeleton interaction in terminally differentiated urothelial cells. It also contributes to the formation of urothelial glycocalyx which may play an important role in preventing bacterial adherence (By similarity). |
Cellular Location | Cell membrane; Single-pass type I membrane protein. Note=Heterodimer formation with UPK1B is a prerequisite to exit out of the endoplasmic reticulum (ER) |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
UPK3B is a minor component of the apical plaques ofmammalian urothelium that binds and dimerizes with uroplakin-1b(UPK1B; MIM 602380), one of the major conserved urothelium membraneproteins. The other major conserved integral membrane proteins ofurothelial plaques are UPK1A (MIM 611557), UPK2 (MIM 611558), andUPK3A (MIM 611559) (Deng et al., 2002 [PubMed 12446744]).[suppliedby OMIM].
References
Foot, N.J., et al. Blood 112(10):4268-4275(2008)Lamesch, P., et al. Genomics 89(3):307-315(2007)Garcia-Espana, A., et al. Mol. Phylogenet. Evol. 41(2):355-367(2006)Deng, F.M., et al. J. Cell Biol. 159(4):685-694(2002)
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.